论文信息 - Efficacy and Safety of Guselkumab, an Interleukin‐23p19–Specific Monoclonal Antibody, Through One Year in Biologic‐Naive Patients With Psoriatic Arthritis - 字舞流文

Efficacy and Safety of Guselkumab, an Interleukin‐23p19–Specific Monoclonal Antibody, Through One Year in Biologic‐Naive Patients With Psoriatic Arthritis

A. Gottlieb | P. Rahman | P. Mease | I. McInnes | S. Chakravarty | Bei Zhou | A. Kollmeier | E. Hsia | Y. Zhuang | Xie L. Xu | S. Sheng | P. Agarwal | Yusang Jiang | R. A. Subramanian | B. Zhou | Désirée van | der Heijde